Top Versus Top: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Home Depot, Inc. (The) (NYSE:HD)

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) closed at $2.37 on the last trading session with an increase of 0%, whereas, it previously closed at $2.37. The company has a market capitalization of $199.91 Million. The company traded shares of 759598 on the trading day while its three month average volume stands at 1.67 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) produced diluted EPS of -0.76. The EPS estimate for next year as estimated by analysts is at -0.66 while EPS for next quarter is estimated at -0.22. Earnings per Share growth for this year is reported at -117.4, while the analysts estimated the EPS growth for next year at -0.66% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -6.5%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stands at 95.19 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) are reported at 4.9 and 5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) stands at -52.3, 217.9 and -213.9 respectively

The trailing twelve month Revenue of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is reported at 2.1 Million with income of -49200000. The outstanding shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) are 84.35 Million. The institutional Ownership of the shares of 16.2 stands at 0.80%, this figure is decreased -16.64 in the last six months. The insider ownership for the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is ticked at 1.7%, the figure is rose 4.61% in the last six months.

Some other important financial aspects to be discussed here for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is the Mean Target Price estimated by the analysts which stands at 7.93. The 52 week high of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is placed at 5.05 and 52 week low is standing at 1.99.

Performance wise the shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) fell down -2.47% for the week, it also fell -28.4% for the monthly performance, while for the quarter it went up -23.3%. The shares decrease -29.46% for the half year and flew up for the Year-To-Date performance. The shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) shrinked -35.95% for the yearly performance.

Home Depot, Inc. (The) (NYSE:HD)

Home Depot, Inc. (The) (NYSE:HD) closed at $198.01 on the last trading session with an decrease of -0.02%, whereas, it previously closed at $198.05. The company has a market capitalization of $217.72 Billion. The company traded shares of 3.71 Million on the trading day while its three month average volume stands at 4.03 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Home Depot, Inc. (The) (NYSE:HD) produced diluted EPS of 9.85. The EPS estimate for next year as estimated by analysts is at 11.01 while EPS for next quarter is estimated at 3.08. Earnings per Share growth for this year is reported at 26.6, while the analysts estimated the EPS growth for next year at 11.01% and Earnings growth for next 5 years stands at 8.92% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 20.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Home Depot, Inc. (The) (NYSE:HD) is at 20.1 while the forward p/e is at 17.99. The P/S or Price to Sales ratio of Home Depot, Inc. (The) (NYSE:HD) stands at 1.99 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 35.98. The quick ratio and the current ratio of Home Depot, Inc. (The) (NYSE:HD) are reported at 0.3 and 1 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Home Depot, Inc. (The) (NYSE:HD) stands at 24, 0 and 44 respectively

The trailing twelve month Revenue of Home Depot, Inc. (The) (NYSE:HD) is reported at 109.64 Billion with income of 11.15 Billion. The outstanding shares of Home Depot, Inc. (The) (NYSE:HD) are 1.1 Billion. The institutional Ownership of the shares of 71.8 stands at 0.80%, this figure is decreased -0.86 in the last six months. The insider ownership for the shares of Home Depot, Inc. (The) (NYSE:HD) is ticked at 0.1%, the figure is plummeted -12.09% in the last six months.

Some other important financial aspects to be discussed here for Home Depot, Inc. (The) (NYSE:HD) is the Mean Target Price estimated by the analysts which stands at 205.86. The 52 week high of Home Depot, Inc. (The) (NYSE:HD) is placed at 215.43 and 52 week low is standing at 158.09.

Performance wise the shares of Home Depot, Inc. (The) (NYSE:HD) rose up 1.41% for the week, it also rise 1.76% for the monthly performance, while for the quarter it went down 7.61%. The shares increase 14.6% for the half year and flew up for the Year-To-Date performance. The shares of Home Depot, Inc. (The) (NYSE:HD) shrinked -0.16% for the yearly performance.